Contact
Ross McNaughton

Ross McNaughton

Partner

Read More
Contact
Ross McNaughton

Ross McNaughton

Partner

Read More

18 January 2022

Conference series widens investor access to cutting-edge healthcare stocks

Call To Action Arrow Image

Latest insights in your inbox

Subscribe to newsletters on topics relevant to you.

Subscribe
Subscribe

Related Insights

Skyline view of traffic
Corporate/M&A & capital markets

Advising EpilepsyGTx on its US$33 million Series A financing

10 December 2025

by multiple authors

Click here to find out more
MAIN_Life sciences
Corporate/M&A & capital markets

Advising on Draig Therapeutics' US$140 million series A financing

23 June 2025

by multiple authors

Click here to find out more
Skyscrapers facades of office buildings
Corporate/M&A & capital markets

Advising Baseimmune on its £9 million funding round

22 March 2024

by Ross McNaughton and Oli Denne

Click here to find out more